CCME Global (BOM:514336) EBITDA Margin %: 0.00% (As of Mar. 2026)


BOM:514336 CCME Global Ltd BOM:514336
26 GF Score
Price ₹114.95
! 2 Warning Signs
View Full Analysis

What is CCME Global EBITDA Margin %?

CCME Global BOM:514336 -4.96% 26 EBITDA Margin % is 0.00% as of Mar. 2026. GuruFocus rates BOM:514336 with a GF Score™ of 26/100. The stock has 2 warning signs investors should review. Among 936 Biotechnology companies, CCME Global ranks worse than 106837.5% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. CCME Global's EBITDA for the three months ended in Mar. 2026 was ₹-5.00 Mil. CCME Global's Revenue for the three months ended in Mar. 2026 was ₹0.00 Mil. Therefore, CCME Global's EBITDA margin for the quarter that ended in Mar. 2026 was 0.00%.

CCME Global  (BOM:514336) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

CCME Global EBITDA Margin % Related Terms

CCME Global EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for CCME Global's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CCME Global EBITDA Margin % Chart

CCME Global Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

CCME Global Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BOM:514336 vs VRTX, REGN, ALNY: EBITDA Margin % Comparison

For the Biotechnology subindustry, CCME Global's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CCME Global EBITDA Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CCME Global's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where CCME Global's EBITDA Margin % falls into.


BOM:514336
26GF Score
CCME Global Ltd BOM:514336
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CCME Global EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

CCME Global's EBITDA Margin % for the fiscal year that ended in Mar. 2026 is calculated as

EBITDA Margin %=EBITDA (A: Mar. 2026 )/Revenue (A: Mar. 2026 )
=-7.147/0
= %

CCME Global's EBITDA Margin % for the quarter that ended in Mar. 2026 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-5/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 0.00% mean?
CCME Global (BOM:514336) has a EBITDA Margin % of 0.00% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on CCME Global and its competitors. According to the industry distribution chart, CCME Global ranks #999999 out of 936 companies in the Biotechnology industry.
Is CCME Global's EBITDA Margin % too high?
CCME Global's current EBITDA Margin % is 0.00%. Based on the distribution chart, CCME Global ranks #999999 out of 936 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, CCME Global has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does CCME Global's EBITDA Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, CCME Global ranks #999999 out of 936 companies for EBITDA Margin %. This places CCME Global in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on CCME Global and its competitors. CCME Global's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CCME Global stock overvalued right now?
CCME Global (BOM:514336) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. CCME Global's overall GF Score™ is 26/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For CCME Global (BOM:514336), the current EBITDA Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CCME Global Business Description

Address Ashok Nagar, Flat no 401, 40-A, VVN Residency, Eluru, AP, IND, 534002
CCME Global Ltd, formerly known as Genesis IBRC India Ltd, is a manufacturer and supplier of Aqua, poultry, veterinary and agriculture products. The product profile promotes health and illness prevention in Aquaculture, poultry and veterinary.
26GF Score

Get the complete analysis for BOM:514336

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹114.95
Price